Jacqueline Capeau Selected Research

Stavudine (Zerit)

9/2019	Metabolic complications affecting adipose tissue, lipid and glucose metabolism associated with HIV antiretroviral treatment.
2/2012	From nonalcoholic fatty liver to nonalcoholic steatohepatitis and cirrhosis in HIV-infected patients: diagnosis and management.
1/2012	Ten-year diabetes incidence in 1046 HIV-infected patients started on a combination antiretroviral treatment.
1/2008	Contribution of mitochondrial dysfunction and oxidative stress to cellular premature senescence induced by antiretroviral thymidine analogues.
1/2007	Some HIV antiretrovirals increase oxidative stress and alter chemokine, cytokine or adiponectin production in human adipocytes and macrophages.
1/2007	A 6-month interruption of antiretroviral therapy improves adipose tissue function in HIV-infected patients: the ANRS EP29 Lipostop Study.
5/2002	Factors related to lipodystrophy and metabolic alterations in patients with human immunodeficiency virus infection receiving highly active antiretroviral therapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jacqueline Capeau Research Topics

Disease

48	Insulin Resistance 01/2022 - 03/2002
37	Lipodystrophy 04/2022 - 03/2002
27	Inflammation (Inflammations) 01/2021 - 01/2007
16	Fibrosis (Cirrhosis) 01/2022 - 08/2004
13	Metabolic Syndrome (Dysmetabolic Syndrome X) 04/2022 - 08/2003
12	Infections 01/2022 - 05/2002
10	Necrosis 01/2019 - 03/2002
9	Obesity 01/2020 - 05/2002
8	HIV Infections (HIV Infection) 01/2021 - 05/2010
8	Cardiovascular Diseases (Cardiovascular Disease) 12/2019 - 12/2010
7	Familial Partial Lipodystrophy (Dunnigan Syndrome) 01/2017 - 01/2003
6	Hypertrophy 01/2022 - 01/2005
6	Type 2 Diabetes Mellitus (MODY) 01/2020 - 08/2003
6	Laminopathies 01/2018 - 06/2005
5	Fatty Liver 11/2014 - 02/2006
5	Dyslipidemias (Dyslipidemia) 01/2013 - 01/2005
4	Mitochondrial Diseases (Mitochondrial Disease) 01/2021 - 01/2008
4	Rheumatoid Arthritis 01/2019 - 01/2013
4	Hepatocellular Carcinoma (Hepatoma) 01/2018 - 12/2002
4	Hypertriglyceridemia 05/2011 - 05/2002
3	Hypertension (High Blood Pressure) 01/2021 - 01/2010
3	Atherosclerosis 01/2021 - 02/2013
3	Weight Gain 12/2020 - 01/2020
3	Neoplasms (Cancer) 01/2020 - 11/2004
3	Disease Progression 01/2014 - 11/2012
3	Non-alcoholic Fatty Liver Disease 06/2012 - 02/2006
3	Premature Aging 12/2011 - 08/2006
3	Acanthosis Nigricans 05/2011 - 01/2005
3	Hyperinsulinism (Hyperinsulinemia) 04/2011 - 08/2003
3	Congenital Generalized Lipodystrophy (Berardinelli-Seip Congenital Lipodystrophy) 03/2010 - 04/2008
2	Osteoporosis 01/2021 - 12/2013
2	Osteoarthritis 01/2021 - 12/2016
2	Alcoholic Fatty Liver 01/2020 - 11/2014
2	Proteinuria 03/2019 - 10/2004
2	Liver Diseases (Liver Disease) 10/2017 - 01/2009
2	Coinfection 01/2017 - 01/2009
2	Dysbiosis 01/2017 - 02/2015
2	Hyperplasia 01/2016 - 10/2010
2	Hypoglycemia (Reactive Hypoglycemia) 01/2016 - 04/2011
2	Viremia 04/2015 - 01/2014
2	Hemolysis 04/2014 - 12/2006

Drug/Important Bio-Agent (IBA)

18	AdiponectinIBA 01/2021 - 07/2003
15	AdipokinesIBA 01/2021 - 07/2003
15	LeptinIBA 01/2020 - 03/2002
14	Protease Inhibitors (Protease Inhibitor)IBA 01/2022 - 03/2002
14	Interleukin-6 (Interleukin 6)IBA 01/2021 - 05/2002
13	Glucose (Dextrose)FDA LinkGeneric 02/2016 - 05/2002
12	Insulin (Novolin)FDA Link 04/2014 - 05/2002
11	Biomarkers (Surrogate Marker)IBA 01/2021 - 05/2008
9	Triglycerides (Triacylglycerol)IBA 01/2021 - 05/2002
9	Lamin Type A (Lamin A)IBA 12/2020 - 01/2003
9	LipidsIBA 01/2020 - 03/2002
9	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2007 - 03/2002
8	Reverse Transcriptase InhibitorsIBA 01/2022 - 05/2002
8	C-Reactive ProteinIBA 01/2015 - 10/2009
7	NucleosidesIBA 01/2022 - 05/2002
7	Proteins (Proteins, Gene)FDA Link 12/2020 - 10/2004
7	Stavudine (Zerit)FDA LinkGeneric 09/2019 - 05/2002
7	LaminsIBA 01/2018 - 01/2003
7	CytokinesIBA 01/2017 - 11/2003
5	IntegrasesIBA 01/2022 - 01/2017
5	Raltegravir Potassium FDA Link 01/2021 - 04/2015
5	Ritonavir (Norvir)FDA Link 01/2020 - 05/2002
5	ThymidineIBA 01/2020 - 01/2008
5	Messenger RNA (mRNA)IBA 11/2016 - 03/2002
5	prelamin AIBA 02/2016 - 12/2010
4	dolutegravirIBA 01/2022 - 01/2017
4	Lipopolysaccharide ReceptorsIBA 01/2021 - 01/2012
4	Viral ProteinsIBA 01/2021 - 01/2017
4	Maraviroc FDA Link 01/2021 - 04/2015
4	CholesterolIBA 01/2021 - 05/2002
4	Zidovudine (Retrovir)FDA LinkGeneric 09/2019 - 01/2007
4	HIV Protease InhibitorsIBA 02/2016 - 11/2003
4	PPAR gammaIBA 01/2010 - 01/2005
4	Nonesterified Fatty Acids (NEFA)IBA 03/2009 - 08/2003
3	HDL CholesterolIBA 01/2021 - 01/2005
3	Integrase InhibitorsIBA 12/2020 - 01/2017
3	Atazanavir Sulfate (Reyataz)FDA Link 01/2020 - 01/2012
3	Biological ProductsIBA 01/2019 - 01/2005
3	Rosiglitazone (Avandia)FDA Link 11/2014 - 11/2003
3	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 11/2014 - 01/2009
3	Lopinavir FDA Link 01/2014 - 01/2007
3	AutoantibodiesIBA 01/2013 - 03/2010
3	Fatty Acids (Saturated Fatty Acids)IBA 06/2012 - 06/2009
3	Insulin ReceptorIBA 04/2011 - 06/2005
3	Glycogen Synthase Kinase 3 betaIBA 07/2005 - 12/2002
2	HDL LipoproteinsIBA 01/2021 - 01/2012
2	fibrin fragment D (D-dimer)IBA 01/2021 - 01/2015
2	Anti-Retroviral Agents (Antiretroviral Agents)IBA 01/2020 - 02/2013
2	Human Immunodeficiency Virus ProteinsIBA 01/2020 - 01/2020
2	Nicotinamide PhosphoribosyltransferaseIBA 01/2020 - 01/2013
2	Transaminases (Aminotransferases)IBA 01/2019 - 02/2006
2	AntioxidantsIBA 12/2017 - 02/2016
2	Pravastatin (Pravachol)FDA LinkGeneric 02/2016 - 01/2014
2	ThiazolidinedionesIBA 11/2014 - 01/2008
2	Pharmaceutical PreparationsIBA 07/2014 - 01/2009
2	Darunavir (Prezista)FDA Link 01/2014 - 01/2012

Therapy/Procedure

27	Therapeutics 01/2021 - 03/2002
8	Highly Active Antiretroviral Therapy (HAART) 01/2020 - 05/2002
6	Art Therapy 01/2021 - 10/2013